An important realization was that it’s not the primary tumor that often claims lives — it’s the spread of cancer to other organs, known as metastasis. Previous studies reported that a daily low-dose ...

"The findings uncover a new way in which the immune system is suppressed, limiting T cells from fighting cancer spread. This ...

Could aspirin keep cancer from spreading? A new study from the University of Cambridge suggests that the common pain ...

The research team discovered that platelets release a substance called thromboxane A2 (TXA2), which attaches to receptors on ...

Aspirin and COX-1 inhibitors boost immunity against cancer metastasis, revealing a new pathway for anti-metastatic therapies.

Through a mouse study, scientists have found that aspirin may help prevent metastases, or secondary tumors, by boosting the body’s immune response.

The scientists traced signals in the cell to determine that ARHGEF1 is switched on when T cells are exposed to a clotting factor called thromboxane ... TXA2 is produced by platelets—a cell ...

The anti-inflammatory pill is known to suppress the molecule thromboxane A2 (TXA2), which is produced by the blood's clotting factor, called platelets. This anti-clotting molecule has led to ...

A new study found that aspirin may help prevent some cancers from spreading by enhancing the immune system’s ability to attack metastatic cells. In the study published March 5 in Nature ...

come into contact with a clotting factor called thromboxane A2 (TXA2). This was surprising because TXA2 is already well known—it plays a role in how aspirin works. TXA2 is made by platelets, the ...

The clotting factor, called thromboxane A2 (TXA2), is made by platelets in the blood - and aspirin is already known to cut its production. By decreasing TXA2 production, aspirin can prevent ...